Emgality is a prescription medication that is used to treat migraines in adults. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) antagonists. Emgality is specifically designed to help reduce the frequency of migraine attacks and is usually administered through subcutaneous injections.
Uses
Emgality is primarily used for the preventative treatment of migraines in adults. It is not intended to treat an ongoing migraine attack. This medication helps reduce the number of monthly migraine days experienced by individuals who suffer from chronic migraines.
Moreover, Emgality has also been approved by the FDA for the treatment of episodic cluster headaches in adults. Cluster headaches are characterized by severe, debilitating pain on one side of the head and are commonly accompanied by other symptoms such as eye redness, nasal congestion, and tearing.
Benefits
Emgality offers several benefits for individuals suffering from chronic migraines or episodic cluster headaches. Some of the key advantages of using Emgality include:
- Reducing the number of migraine days per month
- Lessening the severity and duration of migraine attacks
- Providing relief from cluster headache pain
- Improving overall quality of life by minimizing the impact of migraines or cluster headaches
- Offering a convenient self-administered treatment option through subcutaneous injections
Side Effects
While Emgality can be highly effective, like any medication, it is important to be aware of potential side effects. Some common side effects associated with Emgality include:
- Pain, swelling, or redness at the injection site
- Local skin reactions, such as itching or rash
- Constipation
- Injection site-related reactions, such as itching, bruising, or bleeding
- Dizziness or fatigue
- Headache
- Upper respiratory tract infections
It is crucial to contact your healthcare provider if you experience any severe or persistent side effects while using Emgality.
Warnings
Prior to starting Emgality, it is essential to inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking. Additionally, it is important to be aware of the following warnings:
- Emgality is not recommended for individuals with a known hypersensitivity to galcanezumab-gnlm (the active ingredient in Emgality) or any of its components.
- Emgality should not be used during pregnancy unless the potential benefits outweigh the potential risks to the fetus.
- It is unknown if Emgality passes into breast milk, so it is advised to consult a healthcare provider before using this medication while breastfeeding.
- Emgality may interact with certain medications, including other CGRP antagonists, and caution should be exercised when using multiple medications simultaneously.
FAQs
No, Emgality is not designed to treat acute migraine attacks. It is meant for the prevention of migraines and to reduce their frequency.
The effectiveness of Emgality may vary from person to person. Some individuals may experience a reduction in migraines within a few weeks, while others may take longer. It is recommended to follow the prescribed dosage and discuss progress with your healthcare provider.
No, Emgality is only approved for use in adults aged 18 and above.
Yes, Emgality comes with a prefilled syringe that allows for self-administration. However, it is important to follow the instructions provided by your healthcare provider to ensure proper use.
The effects of Emgality can last up to one month. It is typically administered once a month, and regular usage is important for optimal results.
